Filing Details

Accession Number:
0001567619-18-005093
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-05 17:03:41
Reporting Period:
2018-11-01
Accepted Time:
2018-11-05 17:03:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1514588 Adam Havey 400 Professional Dr, Suite 400
Gaithersburg MD 20879
Evp, Business Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-01 2,011 $25.62 31,264 No 4 M Direct
Common Stock Disposition 2018-11-01 2,011 $63.50 29,253 No 4 S Direct
Common Stock Acquisiton 2018-11-02 6,168 $25.62 35,421 No 4 M Direct
Common Stock Disposition 2018-11-02 6,168 $64.50 29,253 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2018-11-01 2,011 $0.00 2,011 $25.62
Common Stock Stock Option (Right to Buy) Acquisiton 2018-11-02 6,168 $0.00 6,168 $25.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,168 2021-03-10 No 4 M Direct
0 2021-03-10 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
  2. Consists of an option granted under the company's stock incentive plan as amended and restated.
  3. The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant.